{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:18:24Z","timestamp":1792660704320,"version":"4.5.0"},"reference-count":54,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,9,1]]},"abstract":"<jats:p>Nondiabetic obese humans adapt to insulin resistance by increasing \u03b2-cell mass. In contrast, obese humans with type 2 diabetes have an \u223c60% deficit in \u03b2-cell mass. Recent studies in rodents reveal that \u03b2-cell mass is regulated, increasing in response to insulin resistance through increased \u03b2-cell supply (islet neogenesis and \u03b2-cell replication) and\/or decreased \u03b2-cell loss (\u03b2-cell apoptosis). Prospective studies of islet turnover are not possible in humans. In an attempt to establish the mechanism for the deficit in \u03b2-cell mass in type 2 diabetes, we used an obese versus lean murine transgenic model for human islet amyloid polypeptide (IAPP) that develops islet pathology comparable to that in humans with type 2 diabetes. By 40 weeks of age, obese nontransgenic mice did not develop diabetes and adapted to insulin resistance by a 9-fold increase (P &amp;lt; 0.001) in \u03b2-cell mass accomplished by a 1.7-fold increase in islet neogenesis (P &amp;lt; 0.05) and a 5-fold increase in \u03b2-cell replication per islet (P &amp;lt; 0.001). Obese transgenic mice developed midlife diabetes with islet amyloid and an 80% (P &amp;lt; 0.001) deficit in \u03b2-cell mass that was due to failure to adaptively increase \u03b2-cell mass. The mechanism subserving this failed expansion was a 10-fold increase in \u03b2-cell apoptosis (P &amp;lt; 0.001). There was no relationship between the extent of islet amyloid or the blood glucose concentration and the frequency of \u03b2-cell apoptosis. However, the frequency of \u03b2-cell apoptosis was related to the rate of increase of islet amyloid. These prospective studies suggest that the formation of islet amyloid rather than the islet amyloid per se is related to increased \u03b2-cell apoptosis in this murine model of type 2 diabetes. This finding is consistent with the hypothesis that soluble IAPP oligomers but not islet amyloid are responsible for increased \u03b2-cell apoptosis. The current studies also support the concept that replicating \u03b2-cells are more vulnerable to apoptosis, possibly accounting for the failure of \u03b2-cell mass to expand appropriately in response to obesity in type 2 diabetes.<\/jats:p>","DOI":"10.2337\/diabetes.52.9.2304","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"2304-2314","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":356,"title":["Increased \u03b2-Cell Apoptosis Prevents Adaptive Increase in \u03b2-Cell Mass in Mouse Model of Type 2 Diabetes"],"prefix":"10.2337","volume":"52","author":[{"given":"Alexandra E.","family":"Butler","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Janson","sequence":"additional","affiliation":[{"name":"Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C.","family":"Soeller","sequence":"additional","affiliation":[{"name":"Pfizer Global Research and Development, Pfizer, Groton, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Butler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Keck School of Medicine, University of Southern California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031207313859100_R1","doi-asserted-by":"crossref","unstructured":"DeFronzo RA: The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes\u200837:667\u2013687,1988","DOI":"10.2337\/diab.37.6.667"},{"key":"2022031207313859100_R2","doi-asserted-by":"crossref","unstructured":"Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes\u200844:1121\u20131125,1995","DOI":"10.2337\/diabetes.44.9.1121"},{"key":"2022031207313859100_R3","doi-asserted-by":"crossref","unstructured":"Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: \u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type-2 diabetes mellitus. Diabetes\u200852:102\u2013110,2003","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2022031207313859100_R4","doi-asserted-by":"crossref","unstructured":"Tyrberg B, Ustinov J, Otonkoski T, Andersson A: Stimulated endocrine cell proliferation and differentiation in transplanted human pancreatic islets: effects of the ob gene and compensatory growth of the implantation organ. Diabetes\u200850:301\u2013307,2001","DOI":"10.2337\/diabetes.50.2.301"},{"key":"2022031207313859100_R5","doi-asserted-by":"crossref","unstructured":"Kloppel G, Lohr M, Habich K, Oberholzer M, Heitz PU: Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res\u20084:110\u2013125,1985","DOI":"10.1159\/000156969"},{"key":"2022031207313859100_R6","doi-asserted-by":"crossref","unstructured":"Ogilvie R: The islands of Langerhans in 19 cases of obesity. J Pathol\u200837:473\u2013481,1933","DOI":"10.1002\/path.1700370314"},{"key":"2022031207313859100_R7","doi-asserted-by":"crossref","unstructured":"Polonsky KS: Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord\u200824:S29\u2013S31,2000","DOI":"10.1038\/sj.ijo.0801273"},{"key":"2022031207313859100_R8","unstructured":"Clark A, Wells CA, Buley ID, Cruickshank JK, Vanhegan RI, Matthews DR, Cooper GJ, Holman RR, Turner RC: Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res\u20089:151\u2013159,1988"},{"key":"2022031207313859100_R9","doi-asserted-by":"crossref","unstructured":"Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia\u200845:85\u201396,2002","DOI":"10.1007\/s125-002-8248-z"},{"key":"2022031207313859100_R10","doi-asserted-by":"crossref","unstructured":"Kahn SE, Andrikopoulos S, Verchere CB: Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes\u200848:241\u2013253,1999","DOI":"10.2337\/diabetes.48.2.241"},{"key":"2022031207313859100_R11","doi-asserted-by":"crossref","unstructured":"Kudva Y, Butler P: Insulin secretion in type-2 diabetes mellitus. In Clinical Research in Diabetes and Obesity. Draznin B, Rizza R, Eds. Totowa, NJ, Humana Press,1997, p.119\u2013136","DOI":"10.1007\/978-1-4757-3906-0_7"},{"key":"2022031207313859100_R12","doi-asserted-by":"crossref","unstructured":"Bonner-Weir S: Islet growth and development in the adult. J Mol Endocrinol\u200824:297\u2013302,2000","DOI":"10.1677\/jme.0.0240297"},{"key":"2022031207313859100_R13","doi-asserted-by":"crossref","unstructured":"Finegood DT, Scaglia L, Bonner-Weir S: Dynamics of \u03b2-cell mass in the growing rat pancreas: estimation with a simple mathematical model. Diabetes\u200844:249\u2013256,1995","DOI":"10.2337\/diabetes.44.3.249"},{"key":"2022031207313859100_R14","doi-asserted-by":"crossref","unstructured":"Howard CF: Longitudinal studies on the development of diabetes in individual Macaca nigra. Diabetologia\u200829:301\u2013306,1986","DOI":"10.1007\/BF00452067"},{"key":"2022031207313859100_R15","doi-asserted-by":"crossref","unstructured":"Howard CF, Van Bueren A: Changes in islet cell composition during development of diabetes in Macaca nigra. Diabetes\u200835:165\u2013171,1986","DOI":"10.2337\/diabetes.35.2.165"},{"key":"2022031207313859100_R16","doi-asserted-by":"crossref","unstructured":"de Koning EJ, Bodkin NL, Hansen BC, Clark A: Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia\u200836:378\u2013384,1993","DOI":"10.1007\/BF00402271"},{"key":"2022031207313859100_R17","doi-asserted-by":"crossref","unstructured":"Soeller WC, Janson J, Hart SE, Parker JC, Carty MD, Stevenson RW, Kreutter DK, Butler PC: Islet amyloid-associated diabetes in obese A(vy)\/a mice expressing human islet amyloid polypeptide. Diabetes\u200847:743\u2013750,1998","DOI":"10.2337\/diabetes.47.5.743"},{"key":"2022031207313859100_R18","doi-asserted-by":"crossref","unstructured":"Butler PC, Chou J, Carter WB, Wang YN, Bu BH, Chang D, Chang JK, Rizza RA: Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes\u200839:752\u2013756,1990","DOI":"10.2337\/diabetes.39.6.752"},{"key":"2022031207313859100_R19","doi-asserted-by":"crossref","unstructured":"Mulder H, Ahren B, Stridsberg M, Sundler F: Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rats islets following dexamethasone treatment. Diabetologia\u200838:395\u2013402,1995","DOI":"10.1007\/BF00410276"},{"key":"2022031207313859100_R20","doi-asserted-by":"crossref","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA: Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature\u2008368:756\u2013760,1994","DOI":"10.1038\/368756a0"},{"key":"2022031207313859100_R21","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TD, Butler PC, Westermark P, Johnson KH: Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus. Vet Pathol\u200830:317\u2013332,1993","DOI":"10.1177\/030098589303000401"},{"key":"2022031207313859100_R22","doi-asserted-by":"crossref","unstructured":"Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, Kimura H: Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci U S A\u200892:1989\u20131993,1995","DOI":"10.1073\/pnas.92.6.1989"},{"key":"2022031207313859100_R23","doi-asserted-by":"crossref","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC: The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes\u200848:491\u2013498,1999","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2022031207313859100_R24","doi-asserted-by":"crossref","unstructured":"Hiddinga HJ, Eberhardt NL: Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells. Am J Pathol\u2008154:1077\u20131088,1999","DOI":"10.1016\/S0002-9440(10)65360-6"},{"key":"2022031207313859100_R25","unstructured":"Haataja L, Ritzel R, Rhodes CJ, Butler PC: Increased apoptosis in response to adenoviral expression of human islet amyloid polypeptide (Abstract). Diabetes\u200851 (Suppl. 2):A385,2002"},{"key":"2022031207313859100_R26","doi-asserted-by":"crossref","unstructured":"Mirzabekov TA, Lin MC, Kagan BL: Pore formation by the cytotoxic islet amyloid peptide amylin. J Biol Chem\u2008271:1988\u20131992,1996","DOI":"10.1074\/jbc.271.4.1988"},{"key":"2022031207313859100_R27","doi-asserted-by":"crossref","unstructured":"Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT Jr: Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature\u2008418:291,2002","DOI":"10.1038\/418291a"},{"key":"2022031207313859100_R28","doi-asserted-by":"crossref","unstructured":"Hoppener JW, Oosterwijk C, Nieuwenhuis MG, Posthuma G, Thijssen JH, Vroom TM, Ahren B, Lips CJ: Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia\u200842:427\u2013434,1999","DOI":"10.1007\/s001250051175"},{"key":"2022031207313859100_R29","doi-asserted-by":"crossref","unstructured":"Verchere CB, D\u2019Alessio DA, Palmiter RD, Weir GC, Bonner-Weir S, Baskin DG, Kahn SE: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:3492\u20133496,1996","DOI":"10.1073\/pnas.93.8.3492"},{"key":"2022031207313859100_R30","doi-asserted-by":"crossref","unstructured":"Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC: Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide. Proc Natl Acad Sci U S A\u200893:7283\u20137288,1996","DOI":"10.1073\/pnas.93.14.7283"},{"key":"2022031207313859100_R31","doi-asserted-by":"crossref","unstructured":"Couce M, Kane LA, O\u2019Brien TD, Charlesworth J, Soeller W, McNeish J, Kreutter D, Roche P, Butler PC: Treatment with growth hormone and dexamethasone in mice transgenic for human islet amyloid polypeptide causes islet amyloidosis and \u03b2-cell dysfunction. Diabetes\u200845:1094\u20131101,1996","DOI":"10.2337\/diab.45.8.1094"},{"key":"2022031207313859100_R32","doi-asserted-by":"crossref","unstructured":"Geisler JG, Zawalich W, Zawalich K, Lakey JR, Stukenbrok H, Milici AJ, Soeller WC: Estrogen can prevent or reverse obesity and diabetes in mice expressing human islet amyloid polypeptide. Diabetes\u200851:2158\u20132169,2002","DOI":"10.2337\/diabetes.51.7.2158"},{"key":"2022031207313859100_R33","doi-asserted-by":"crossref","unstructured":"Duhl DM, Vrieling H, Miller KA, Wolff GL, Barsh GS: Neomorphic agouti mutations in obese yellow mice. Nat Genet\u20088:59\u201365,1994","DOI":"10.1038\/ng0994-59"},{"key":"2022031207313859100_R34","doi-asserted-by":"crossref","unstructured":"Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL: Obesity, diabetes, and neoplasia in yellow A(vy)\/- mice: ectopic expression of the agouti gene. FASEB J\u20088:479\u2013488,1994","DOI":"10.1096\/fasebj.8.8.8181666"},{"key":"2022031207313859100_R35","doi-asserted-by":"crossref","unstructured":"Buchanan A: Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes. J Clin Endocrinol Metab\u200886:989\u2013993,2001","DOI":"10.1210\/jcem.86.3.7339"},{"key":"2022031207313859100_R36","doi-asserted-by":"crossref","unstructured":"Klebig ML, Wilkinson JE, Geisler JG, Woychik RP: Ectopic expression of the agouti gene in transgenic mice causes obesity, features of type II diabetes, and yellow fur. Proc Natl Acad Sci U S A\u200892:4728\u20134732,1995","DOI":"10.1073\/pnas.92.11.4728"},{"key":"2022031207313859100_R37","doi-asserted-by":"crossref","unstructured":"Scaglia L, Smith FE, Bonner-Weir S: Apoptosis contributes to the involution of beta cell mass in the post partum rat pancreas. Endocrinology\u2008136:5461\u20135468,1995","DOI":"10.1210\/endo.136.12.7588296"},{"key":"2022031207313859100_R38","doi-asserted-by":"crossref","unstructured":"McMahon M, Gerich J, Rizza RA: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev\u20084:17\u201330,1988","DOI":"10.1002\/dmr.5610040105"},{"key":"2022031207313859100_R39","doi-asserted-by":"crossref","unstructured":"Rosenbloom AL, Joe JR, Young RS, Winter WE: Emerging epidemic of type 2 diabetes in youth. Diabetes Care\u200822:345\u2013354,1999","DOI":"10.2337\/diacare.22.2.345"},{"key":"2022031207313859100_R40","doi-asserted-by":"crossref","unstructured":"Goran MI, Gower BA: Longitudinal study on pubertal insulin resistance. Diabetes\u200850:2444\u20132450,2001","DOI":"10.2337\/diabetes.50.11.2444"},{"key":"2022031207313859100_R41","doi-asserted-by":"crossref","unstructured":"Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced \u03b2-cell apoptosis in pancreatic islets of psammomys abesus during development of diabetes. Diabetes\u200848:738\u2013744,1999","DOI":"10.2337\/diabetes.48.4.738"},{"key":"2022031207313859100_R42","doi-asserted-by":"crossref","unstructured":"Ritzel RA, Butler PC: Replication increases beta cell vulnerability to human islet amyloid polypeptide induced apoptosis. Diabetes\u200852:1701\u20131708,2003","DOI":"10.2337\/diabetes.52.7.1701"},{"key":"2022031207313859100_R43","doi-asserted-by":"crossref","unstructured":"Maedler K, Fontana A, Ris F, Sergeev P, Toso C, Oberholzer J, Lehmann R, Bachmann F, Tasinato A, Spinas GA, Halban PA, Donath MY: FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication. Proc Natl Acad Sci U S A\u200899:8236\u20138241,2002","DOI":"10.1073\/pnas.122686299"},{"key":"2022031207313859100_R44","doi-asserted-by":"crossref","unstructured":"Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E: \u03b2-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes\u200851:66\u201372,2002","DOI":"10.2337\/diabetes.51.1.66"},{"key":"2022031207313859100_R45","doi-asserted-by":"crossref","unstructured":"Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patane G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P: Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that \u03b2-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes\u200851:1437\u20131442,2002","DOI":"10.2337\/diabetes.51.5.1437"},{"key":"2022031207313859100_R46","doi-asserted-by":"crossref","unstructured":"Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A\u200895:2498\u20132502,1998","DOI":"10.1073\/pnas.95.5.2498"},{"key":"2022031207313859100_R47","doi-asserted-by":"crossref","unstructured":"Bell ET: Hyalinization of the islets of Langerhans in diabetes mellitus. Diabetes\u20081:341\u2013344,1952","DOI":"10.2337\/diab.1.5.341"},{"key":"2022031207313859100_R48","unstructured":"Ehrlich JG, Ratner JM: Amyloidosis of the islets of Langerhans: a restudy of the islets hyaline in diabetic and non diabetic individuals. Am J Pathol\u200838:49\u201359,1961"},{"key":"2022031207313859100_R49","doi-asserted-by":"crossref","unstructured":"Maloy AL, Longnecker DS, Greenberg ER: The relation of islet amyloid to the clinical type of diabetes. Hum Pathol\u200812:917\u2013922,1981","DOI":"10.1016\/S0046-8177(81)80197-9"},{"key":"2022031207313859100_R50","doi-asserted-by":"crossref","unstructured":"Opie EL: The relationship of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islets of langerhans. J Exp Med\u20085:527\u2013540,1901","DOI":"10.1084\/jem.5.5.527"},{"key":"2022031207313859100_R51","doi-asserted-by":"crossref","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Glabe CG: Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science\u2008300:486\u2013489,2003","DOI":"10.1126\/science.1079469"},{"key":"2022031207313859100_R52","doi-asserted-by":"crossref","unstructured":"O\u2019Brien TD, Butler AE, Roche PC, Johnson KH, Butler PC: Islet amyloid polypeptide in human insulinomas: evidence for intracellular amyloidogenesis. Diabetes\u200843:329\u2013336,1994","DOI":"10.2337\/diabetes.43.2.329"},{"key":"2022031207313859100_R53","doi-asserted-by":"crossref","unstructured":"Muchowski PJ: Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?Neuron\u200835:9\u201312,2002","DOI":"10.1016\/S0896-6273(02)00761-4"},{"key":"2022031207313859100_R54","doi-asserted-by":"crossref","unstructured":"Johnson JL, Craig EA: Identifying functional interactions with molecular chaperones. Methods Enzymol\u2008351:442\u2013453,2002","DOI":"10.1016\/S0076-6879(02)51863-2"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/52\/9\/2304\/650281\/db0903002304.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/52\/9\/2304\/650281\/db0903002304.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:19:05Z","timestamp":1667405945000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/52\/9\/2304\/11498\/Increased-Cell-Apoptosis-Prevents-Adaptive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,1]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.52.9.2304","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,1]]}}}